BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Press Releases

  AN2 Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business and Scientific Highlights

  March 18, 2026

   · 

  13 min read
• Press Releases

  Personalis Appoints Dr. Richard Chen as President to Further Accelerate MRD Adoption

  March 18, 2026

   · 

  5 min read
• 

  Mergers & acquisitions

  In Tight Deal Environment, Pharma May Need To Think Big

  The major pharmas are loaded up with trillions in firepower—but are sticking to mid-cap deals. One expert says it might be time to think outside the box and shake up the industry with some consolidation.

  March 18, 2026

   · 

  5 min read

   · 

  Annalee Armstrong
• Press Releases

  Boundless Bio Announces Upcoming Presentation of Oral Kinesin Degrader Program at the American Association for Cancer Research Annual Meeting 2026

  March 18, 2026

   · 

  1 min read
• Press Releases

  OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter from Altai Capital

  March 18, 2026

   · 

  11 min read
• Press Releases

  Xilio Therapeutics to Present New Preclinical Data for its Masked T Cell Engager Program Targeting CLDN18.2 at the American Association for Cancer Research (AACR) Annual Meeting

  March 18, 2026

   · 

  3 min read
• Press Releases

  Immuneering to Present Molecular Data at 2026 AACR Annual Meeting from Atebimetinib-Treated Patients, Highlighting Mechanism Designed to Improve Durability and Survival

  March 18, 2026

   · 

  5 min read
• Press Releases

  Adagene’s Muzastotug (ADG126) to be Highlighted in Two Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting in San Diego, CA

  March 18, 2026

   · 

  2 min read
• Press Releases

  Tonix Pharmaceuticals Announces Oral Presentation and Two Poster Presentations on Preclinical Immuno-oncology Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026

  March 18, 2026

   · 

  4 min read
• Press Releases

  Prelude Therapeutics Announces Acceptance of Preclinical Abstract for PRT13722, a First-in-Class Oral KAT6A Selective Degrader at the 2026 AACR Annual Meeting

  March 18, 2026

   · 

  5 min read